Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 4.9 (288 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.7 (49 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 23.18 Min. order: 1 piece ★★★★★ 4.1 (151 reviews) Sold : Login>>
PRP Injection for Knee Pain Relief US$ 26.81 Min. order: 1 piece ★★★★★ 4.7 (201 reviews) Sold : Login>>